Novel ampk activators for the treatment of lithium-induced nephrogenic diabetes insipidus
Ended Project Grant Awarded Last action
- Award ID
- R41DK127798
- Recipient
-
Nephrodi Therapeutics, Inc. UEI KZLUNSSJLA83
- Awarding agency
-
National Institute of Diabetes and Digestive and Kidney Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $297,609
Award facts
- Assistance listing
- 93.847 Diabetes, Digestive, and Kidney Diseases Extramural Research
- Completion date
- Originally
- Place of performance
- Philadelphia, PA 19103, USA
Award details come from USAspending.gov.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $0 | |
| Original award | $297,609 |
Quick answers
Who received award R41DK127798?
R41DK127798 was awarded to Nephrodi Therapeutics, Inc. by National Institute of Diabetes and Digestive and Kidney Diseases (National Institutes of Health) on September 15, 2020.
How much is award R41DK127798 worth?
$297,609 has been obligated on R41DK127798.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award